Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on September 23, 2008
JNCI Journal of the National Cancer Institute 2008 100(19):1337; doi:10.1093/jnci/djn370
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/19/1337-a    most recent
djn370v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008.

MEMO TO THE MEDIA

Observational Study Suggests Hormone Therapy Safe for Postmenopausal BRCA Mutation Carriers

The first 10% of the full text of this article appears below.

The use of hormone therapy was associated with a reduced risk of breast cancer in postmenopausal women who carry BRCA mutations, according to a case-control study published online September 23 in the Journal of the National Cancer Institute.

Women who carry a mutation in the BRCA1 gene may opt . . . [Full Text of this Article]

Contact:

Citation:


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers
Andrea Eisen, Jan Lubinski, Jacek Gronwald, Pal Moller, Henry T. Lynch, Jan Klijn, Charmaine Kim-Sing, Susan L. Neuhausen, Lucy Gilbert, Parviz Ghadirian, Siranoush Manoukian, Gad Rennert, Eitan Friedman, Claudine Isaacs, Eliot Rosen, Barry Rosen, Mary Daly, Ping Sun, Steven A. Narod, and the Hereditary Breast Cancer Clinical Study Group
J Natl Cancer Inst 2008 100: 1361-1367. [Abstract] [Full Text] [PDF]

Menopausal Hormone Therapy in BRCA1 Mutation Carriers: Uncertainty and Caution
Rowan T. Chlebowski and Ross L. Prentice
J Natl Cancer Inst 2008 100: 1341-1343. [Extract] [Full Text] [PDF]